Healthcare Stocks with Lowest Price/Earnings Ratio (IPXL, MRK, LLY)

Impax Lab Inc. (NASDAQ:IPXL) stock is trading at $16.50, down 0.96% from its last close. The company stock has traded in the range of $0.18-$22.39 in last 52 weeks.  . The company’s market cap is $1.06 billion and its EV/Revenue ratio is 1.00. Impax Lab stock has a 50-day moving average of $16.94, whereas its 200-days moving average is $17.73. The company beta is 0.29 and its EPS stands at $3.28. The company’s generating 30.95% return on its assets and its rate of return on equity is 71.87%. Impax Lab’s stock is trading at a P/E ratio of 5.08.

Subscribe to daily free stock newsletter by visiting:  http://www.PennyStockPickReport.com

Impax Lab is a technology based pharmaceutical firm. The company develops and markets brand-name and bioequivalent drugs. The company has divided its business into two segments viz. Global division and Impax Division.

Merck (NYSE:MRK) stock is currently trading at $34.63, up 0.44%. Merck stock has traded in the range of $30.70-$41.56 during last 52 weeks. Its 50 days average is $35.38 and its 200 days average is $35.95. The company’s beta is 0.85 and its EPS is $4.79. Merck’s market cap is $110.26 billion. The company’s P/E ratio is 7.38.

Merck has been hit with a probe from Department of Justice and The Securities and Exchange Commission. These agencies will see if the company has violated anti-bribery laws in foreign countries.

Subscribe to daily free stock newsletter by visiting:  http://www.PennyStockPickReport.com

Eli Lilly & Co. (NYSE:LLY) is currently trading at $44.94, and it is down by 0.03%. Eli Lilly stock has traded in the range of $32.02-$38.00 in last 52 weeks. The company’s market cap is $43.55 billion and its EPS stands at $4.04. Eli Lilly’s stock is trading at a Price/Sales ratio of 1.67 and its beta is 0.78. Eli Lilly stock is trading at Price/Book ratio of 3.98 and its EV/Revenue ratio is 1.87. Eli Lilly & Co. stock is trading at a P/E ratio of 8.40.

Eli Lilly has reported 16 percent jump in its profit for the second quarter of the year. The company has raised its full year EPS view. The company’s new guidance is $4.44-$4.59, up from a previous range of $4.35-$4.50.

About http://www.PennyStockPickReport.com

Penny Stock Pick Report offers stock newsletter on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.